Back to User profile » Professor Seung Up Kim

Papers published by Professor Seung Up Kim:

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients

Yim HJ, Kim JH, Cho YK, Kweon YO, Cho HC, Hwang JS, Lee C, Koh MS, Baek YH, Park YM, Lee JH, Kim SU, Kang MK, Park NH, Lee JS, Chon YE, Cheon GJ, Chae HB, Sohn JH, Lim YS

Drug Design, Development and Therapy 2022, 16:3263-3274

Published Date: 23 September 2022

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B

Lee HW, Lee HW, Lee JS, Roh YH, Lee H, Kim SU, Park JY, Kim DY, Ahn SH, Kim BK

Journal of Hepatocellular Carcinoma 2021, 8:467-476

Published Date: 25 May 2021

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, Kim BK

Journal of Hepatocellular Carcinoma 2020, 7:403-412

Published Date: 17 December 2020

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib

Lee SH, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH

Journal of Hepatocellular Carcinoma 2015, 2:39-47

Published Date: 28 April 2015

Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma

Lee SH, Kim SU, Jang JW, Bae SH, Lee SH, Kim BK, Park JY, Kim DY, Ahn SH, Han KH

OncoTargets and Therapy 2015, 8:347-356

Published Date: 2 February 2015

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma

Yoo EJ, Shin HS, Kim SU, Joo DJ, Park JY, Choi GH, Kim DY, Ahn SH, Seong J, Koh MJ, Han KH, Chon CY

OncoTargets and Therapy 2013, 6:755-759

Published Date: 21 June 2013